Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BNOS 2022 | Drug delivery challenges in glioblastoma

Christopher McConville, PhD, University of Birmingham, Birmingham, UK, describes difficulties in delivering drugs in glioblastoma. The blood-brain barrier can prevent the therapeutic dose of a certain medication from entering the brain and novel therapies often have a dose limiting toxicity, preventing clinicians from administering higher doses. With a limited number of therapies such as temozolomide being able to reach the brain, there is need to optimize drug delivery. This interview took place at the British Neuro-Oncology Society (BNOS) Annual Meeting 2022.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.